These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
716 related items for PubMed ID: 22387599
1. Analysis of serum genome-wide microRNAs for breast cancer detection. Wu Q, Wang C, Lu Z, Guo L, Ge Q. Clin Chim Acta; 2012 Jul 11; 413(13-14):1058-65. PubMed ID: 22387599 [Abstract] [Full Text] [Related]
2. Identification and characterization of novel microRNA candidates from deep sequencing. Wu Q, Wang C, Guo L, Ge Q, Lu Z. Clin Chim Acta; 2013 Jan 16; 415():239-44. PubMed ID: 23153516 [Abstract] [Full Text] [Related]
3. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, Tang J, Chen X, Dai J, Wei Q, Zhang C, Shen H. Carcinogenesis; 2012 Apr 16; 33(4):828-34. PubMed ID: 22298638 [Abstract] [Full Text] [Related]
4. Decreased serum miR-181a is a potential new tool for breast cancer screening. Guo LJ, Zhang QY. Int J Mol Med; 2012 Sep 16; 30(3):680-6. PubMed ID: 22692639 [Abstract] [Full Text] [Related]
5. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K. Cancer Res; 2010 Dec 01; 70(23):9798-807. PubMed ID: 21098710 [Abstract] [Full Text] [Related]
6. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H. Cancer Lett; 2012 Mar 28; 316(2):196-203. PubMed ID: 22169097 [Abstract] [Full Text] [Related]
7. Next-generation sequencing of microRNAs for breast cancer detection. Wu Q, Lu Z, Li H, Lu J, Guo L, Ge Q. J Biomed Biotechnol; 2011 Mar 28; 2011():597145. PubMed ID: 21716661 [Abstract] [Full Text] [Related]
8. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer. Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z. Breast Cancer Res Treat; 2015 Nov 28; 154(2):423-34. PubMed ID: 26476723 [Abstract] [Full Text] [Related]
9. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Ann Surg; 2010 Mar 28; 251(3):499-505. PubMed ID: 20134314 [Abstract] [Full Text] [Related]
10. Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects. Gu H, Li H, Zhang L, Luan H, Huang T, Wang L, Fan Y, Zhang Y, Liu X, Wang W, Yuan Z. J Neurochem; 2012 Aug 28; 122(3):641-9. PubMed ID: 22642222 [Abstract] [Full Text] [Related]
11. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. Shimizu T, Suzuki H, Nojima M, Kitamura H, Yamamoto E, Maruyama R, Ashida M, Hatahira T, Kai M, Masumori N, Tokino T, Imai K, Tsukamoto T, Toyota M. Eur Urol; 2013 Jun 28; 63(6):1091-100. PubMed ID: 23200812 [Abstract] [Full Text] [Related]
12. miRNA profiling reveals a potential role of milk stasis in breast carcinogenesis. Gu YQ, Gong G, Xu ZL, Wang LY, Fang ML, Zhou H, Xing H, Wang KR, Sun L. Int J Mol Med; 2014 May 28; 33(5):1243-9. PubMed ID: 24584717 [Abstract] [Full Text] [Related]
13. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ. Gut; 2009 Oct 28; 58(10):1375-81. PubMed ID: 19201770 [Abstract] [Full Text] [Related]
14. miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Kastl L, Brown I, Schofield AC. Breast Cancer Res Treat; 2012 Jan 28; 131(2):445-54. PubMed ID: 21399894 [Abstract] [Full Text] [Related]
15. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. RNA; 2008 Nov 28; 14(11):2348-60. PubMed ID: 18812439 [Abstract] [Full Text] [Related]
16. Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients. Keller A, Backes C, Leidinger P, Kefer N, Boisguerin V, Barbacioru C, Vogel B, Matzas M, Huwer H, Katus HA, Stähler C, Meder B, Meese E. Mol Biosyst; 2011 Dec 28; 7(12):3187-99. PubMed ID: 22027949 [Abstract] [Full Text] [Related]
17. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Yousef GM. J Urol; 2011 Sep 28; 186(3):1077-83. PubMed ID: 21784468 [Abstract] [Full Text] [Related]
18. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases. Xiong DD, Lv J, Wei KL, Feng ZB, Chen JT, Liu KC, Chen G, Luo DZ. Oncol Rep; 2017 Jun 28; 37(6):3297-3304. PubMed ID: 28440475 [Abstract] [Full Text] [Related]
19. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study. Wu J, Lu C, Diao N, Zhang S, Wang S, Wang F, Gao Y, Chen J, Shao L, Lu J, Zhang X, Weng X, Wang H, Zhang W, Huang Y. Hum Immunol; 2012 Jan 28; 73(1):31-7. PubMed ID: 22037148 [Abstract] [Full Text] [Related]
20. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M. Int J Oncol; 2011 Jul 28; 39(1):13-21. PubMed ID: 21519788 [Abstract] [Full Text] [Related] Page: [Next] [New Search]